معرفی
Ruaidhri Carmody is a Reader in Molecular Biosciences at the University of Glasgow. His research focuses on identifying nuclear regulatory events that shape the transcriptional outcomes of NF-κB activation, particularly during Toll-like receptor signaling. He has contributed significantly to understanding the role of nuclear IκB proteins like Bcl-3 and deubiquitinases such as USP7 in modulating inflammation and immune responses.
Research Interests
- NF-κB signaling and transcriptional regulation
- Nuclear events in inflammation and immunity
- Ubiquitination and deubiquitination mechanisms
- Therapeutic targeting of inflammatory diseases
Article Trends His recent publications highlight the interplay between NF-κB and nuclear regulators in inflammation, cancer, and autoimmune diseases. Key themes include Toll-like receptor signaling, deubiquitinase enzymes, and the development of anti-inflammatory peptides. These works span disciplines such as molecular biology, immunology, and oncology, emphasizing translational potential in treating conditions like rheumatoid arthritis and leukemia.
Grants
- BBSRC: Structure-function analysis of USP7 and NF-κB interaction (2020–2022)
- Tenovus Scotland: Selective targeting of NF-κB by Bcl-3 (2016–2017)
- Medical Research Council: Investigating NF-κB p50 phosphorylation (2015–2018)
- BBSRC: Dissecting Bcl-3 function in B cells (2015–2018)
- Arthritis Research UK: Developing USP7 as a therapeutic target in rheumatoid arthritis (2014–2015)
